Search by Drug Name or NDC
NDC 13925-0515-10 Pentamidine Isethionate 300 mg/300mg Details
Pentamidine Isethionate 300 mg/300mg
Pentamidine Isethionate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Seton Pharmaceuticals. The primary component is PENTAMIDINE ISETHIONATE.
MedlinePlus Drug Summary
Pentamidine injection is used to treat pneumonia caused by a fungus called Pneumocystis carinii. It is in a class of medications called antiprotozoals. It works by stopping the growth of protozoa that can cause pneumonia.
Related Packages: 13925-0515-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pentamidine Injection
Product Information
NDC | 13925-0515 |
---|---|
Product ID | 13925-515_8b18239a-6f0e-42ce-8411-d3d1819c131f |
Associated GPIs | 16000045002130 |
GCN Sequence Number | 009599 |
GCN Sequence Number Description | pentamidine isethionate VIAL 300 MG INJECTION |
HIC3 | W4K |
HIC3 Description | ANTIPROTOZOAL DRUGS,MISCELLANEOUS |
GCN | 42990 |
HICL Sequence Number | 004162 |
HICL Sequence Number Description | PENTAMIDINE ISETHIONATE |
Brand/Generic | Generic |
Proprietary Name | Pentamidine Isethionate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pentamidine Isethionate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 300 |
Active Ingredient Units | mg/300mg |
Substance Name | PENTAMIDINE ISETHIONATE |
Labeler Name | Seton Pharmaceuticals |
Pharmaceutical Class | Antiprotozoal [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206666 |
Listing Certified Through | 2024-12-31 |
Package
NDC 13925-0515-10 (13925051510)
NDC Package Code | 13925-515-10 |
---|---|
Billing NDC | 13925051510 |
Package | 10 VIAL in 1 TRAY (13925-515-10) / 300 mg in 1 VIAL |
Marketing Start Date | 2018-04-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |